FinanceAsianet Newsable
FBRX Stock On Track For Highest Levels In Over 4.5 Years As ArgenX Scoops Up Autoimmune Drug Maker
in5points
ArgenX is acquiring Forte Biosciences, adding to its immunology portfolio.
The acquisition complements ArgenX's existing autoimmune and neuromuscular disease therapies.
FBRX stock is on track for its highest levels in over 4.5 years.
Story angle
Center-right
L
CL
C
CR
R
Mostly straight facts, with a light government- or market-friendly tilt.
About how the story is framed, not whether the facts are true.
Asianet Newsable
Center-right
Mixed factuality
Who owns this?
Asianet News Network
Rajeev Chandrasekhar / Jupiter Capital interests historically